(Ozempic and Wegovy are both the same moleculesemaglutideand are made and sold by Novo Nordisk.) In 2023, a clinical trial called Semaglutide Effects on Cardiovascular Outcomes in People With Overweight or Obesity (SELECT) showed that Wegovy can significantly reduce the risk of major heart eventsthis time in people with extra weight and a cardiovascular condition who dont have diabetes
Understanding what to expect after stopping, and how to best support your body, is key to maintaining long-term results
PMID: 41984014, DOI: 10.1016/j.jacc.2026.02.5112
Patients are encouraged to check in regularly with their provider via the secure portal, especially if they experience side effects, plateau in progress, or need help with lifestyle adjustments
Rabobank: Its way too early to draw conclusions However, Nick Fereday, senior analyst, consumer foods at Rabobank, says we should be careful about making sweeping predictions about the future of the food industry based on preliminary survey data from a relatively small number of GLP-1 drug users